SNA vs TBPH · P/E 17, rev $1.33B vs P/E 7.5, rev $38.4M
Snap-On Inc (SNA) versus Theravance Biopharma Inc (TBPH) — a side-by-side from cached financials, not a winner call.
Snap-On Inc (SNA) is a tools & accessories company listed on US.
Theravance Biopharma Inc (TBPH) is a biotechnology company listed on NASDAQ.
Latest reported SNA revenue for 2026-07-04 was $1.33B. Net income was $260.6M. Revenue was up 2.0% from 2026-04-04 to 2026-07-04. SNA currently screens at market cap $16.82B and trailing P/E 16.8.
Latest reported TBPH revenue for 2026-06-30 was $38.4M. Net income was -$10.8M. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
SNA currently screens at market cap $16.82B and trailing P/E 16.8. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
Not investment advice. Open the SNA and TBPH stock pages for the full models.
Not investment advice.